CBD (CANNABIDIOL) IV INFUSION

---

We are proud to partner with Pico IV, revolutionizing wellness with sterile CBD infusion technology. This groundbreaking collaboration brings together the best of CBD and IV therapy, offering a unique approach to health and well-being.

Pico IV’s patent-pending technology has overcome a longstanding challenge in Cannabidiol administration. By shrinking the CBD molecule to picometer size – one trillionth of a meter – and making it water-soluble, they’ve created a true pico emulsion. This innovation allows the Cannabidiol to pass through sterile filters, ensuring a safe and potent intravenous product.

Unlike traditional CBD delivery methods, Pico IV’s sterile Cannabidiol solution offers nearly 100% absorption directly into the bloodstream. This breakthrough in bioavailability opens up new possibilities for those seeking the therapeutic benefits of CBD in a clinical setting.

The pico emulsion breakthrough enables direct administration of cannabidiol into the bloodstream via IV infusion. This method offers several advantages over traditional CBD delivery:

1. Rapid absorption
2. Maximized bioavailability (nearly 100%)
3. Potential for enhanced therapeutic effects

By bypassing digestive processes, CBD IV therapy ensures that a higher concentration of the compound reaches the body’s endocannabinoid system, potentially amplifying its benefits.

This pioneering approach opens new possibilities for Cannabidiol use in clinical settings, offering precise dosing and controlled administration for those seeking the therapeutic potential of cannabidiol in a medical environment.

Functions Regulated By The ECS and Potential Benefits of CBD

1. Pain Relief: IV CBD may help reduce chronic pain by influencing pain signaling pathways and modulating inflammation.
2. Anxiety Reduction: Supports mood stabilization and alleviates symptoms of anxiety disorders.
3. Sleep Improvement: Promotes better sleep quality by addressing factors like anxiety and pain.
4. Immune Support: Helps modulate immune responses and reduce inflammation.
5. Neuroprotective Properties: Could have benefits in neurological disorders like Parkinson's, Alzheimer's, and multiple sclerosis.
6. Seizure Management: Approved by the FDA in rare and severe forms of epilepsy like Dravet syndrome.
7. Nausea Reduction: May be helpful in reducing nausea and vomiting, especially associated with cancer chemotherapy.
8. Reduce Brain Fog: By alleviating inflammation and anxiety, it helps eliminate brain fog, leading to improved focus and enhanced cognitive performance.
9. Cardiovascular Health: Early research suggests potential benefits for blood pressure regulation and reducing oxidative stress.
10. Lower Depression and P.T.S.D: it can reduce the frequency of flashbacks, anxiety, and other related symptoms by helping to stabilize mood and support emotional regulation.
11. Potential Anticancer Properties: Preliminary studies point towards possible effects on slowing tumor growth and reducing cancer-related symptoms, but significantly more research is needed.
12. Research is Ongoing: Scientists are continuously exploring new potential benefits and refining our understanding of CBD's effects.

Endocannabinsides: These naturally occurring molecules, like anandaminde and 2-arachidonoylglycerol, act as chemical messengers in the ECS, binding to receptors to regulate bodily functions.

Cannabinoid Receptors:

• CB1 Receptors: Located primarily in the brain and nervous system, influencing mood, memory and pain.
• CB2 Receptors: Found in the immune system, involved in inflammation and immune response.

It is imperative to underscore that CBD is non-psychoactive.This fundamental characteristic of Cannabidiol highlights its distinctive nature as a therapeutic agent. CBD IV therapy delivers the therapeutic merits of CBD without eliciting any psychotropic or mind-altering effects, affirming that users can derive its manifold advantages devoid of concerns related to alterations in cognitive perception or experiencing a ‘high.’

This non-psychoactive property of Cannabidiol is attributed to its selective interaction with specific receptors in the endocannabinoid system, primarily the CB1 receptor. Unlike its cannabinoid counterpart, THC (tetrahydrocannabinol), which binds strongly with CB1 receptors and induces psychoactivity, CBD demonstrates a notably low affinity for these receptors. Consequently, CBD’s engagement with the endocannabinoid system remains nuanced, focusing on modulation rather than stimulation.

This modulation of the endocannabinoid system, in conjunction with interactions with other receptors and signaling pathways, enables CBD to impart its therapeutic benefits while preserving mental clarity and sobriety. Users can confidently embrace CBD IV therapy as a precise and controlled means of harnessing the therapeutic potential of Cannabidiol without the cognitive or perceptual shifts associated with traditional cannabis use, thus making it an appealing and pragmatic choice for a wide range of therapeutic applications.

Remarkably, CBD IV therapy distinguishes itself through its absence of THC, the psychoactive compound predominantly associated with cannabis. This salient feature underscores a commitment to ensuring that users can engage with Cannabidiol for therapeutic purposes in a manner that is devoid of any THC-related concerns.

The absence of THC in CBD IV therapy is of paramount importance, as it guarantees that users will not experience the characteristic psychoactive effects, such as euphoria or altered perception, commonly associated with THC. This commitment to THC-free formulations is aligned with the principles of safety and responsibility in cannabinoid-based therapies.

Moreover, this absence of THC is advantageous for individuals subject to drug testing, as it eliminates any possibility of a positive result for THC metabolites in standard drug screenings. In summary, CBD IV therapy offers users a trustworthy and scientifically vetted means of harnessing the therapeutic potential of Cannabidiol, while simultaneously providing the peace of mind that they are not exposed to any psychoactive effects or THC-related concerns.

The Jarisch-Herxheimer Reaction is an inflammatory response that can include fever, chills, headache, muscle aches, fatigue, and nausea. The exact cause of the Herxheimer reaction is not fully understood, but it is thought to be due to the release of toxins from dying bacteria or other pathogens.

 
Who CANNOT take CBD/CBG?
Absolute contraindications to CBD/CBG are allergies to Cannabis (in any form or strength) or Sesame Oil. ANY sign of skin irritation, or allergic/anaphylactic reaction, the IV will be stopped immediately with no refund to patient.

Health considerations with using CBD/CBG?
CBD/CBG may be harmful to your liver. CBD/CBG may raise levels of liver enzymes. And this could indicate liver damage.In most cases, this happens with very high doses of CBD/CBG or when it’s taken with certain medications.   

What Drugs Should NOT be Taken With CBD/CBG?

• Antiarrhythmics & anticoagulants- Flecainide or Warfarin
• Antibiotics-  Azithromycin or Ofloxacin
• Antidepressants-  Fluoxetine
• Anticonvulsants/ Antiepileptic Medication- Lamictal, Diazepam, Dilantin, Lamotrigine, Phenytoin, Phenobarbital, Hexobarbital, Valproic Acid and Narcotics such as Codeine and Morphine
• 
  

Precaution When Taking CBD/CBG:

• Antihypertensive- CBD/CBG can interact with blood pressure medication, changing the blood concentration of these drugs

In Full Compliance with Federal Law and THC Standards:

Cannabidiol enjoys federal legality across all 50 states, a milestone achieved through the regulatory framework established by the 2018 Farm Bill. It’s worth noting that our CBD products adhere rigorously to these federal standards, containing an absolute absence of Delta 9 THC, the psychoactive component found in cannabis. This ensures that our CBD offerings align seamlessly with the legal landscape set forth by the Farm Bill, offering consumers peace of mind and confidence in their compliance with federal regulations.

In Alaska only consumers 21 years of age or older may purchase or consume CBD products. 

CBD retailers must register with the Alaska Division of Agriculture before selling any products for human consumption that contain CBD.

Resurrection Medical Care is a registered retailer for human consumption of CBD as well as PICOIV sterile CBD IV solution is approved through the Alaska Industrial Hemp Program through the Department of Natural Resources. 

*These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not indented to diagnose, treat, cure, or prevent any disease*